Topotecan in Treating Children With Refractory Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of topotecan in treating children with refractory
leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so
they stop growing or die.